SLMC:F:F-iShares MSCI Europe ESG Screened UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 9.092

Change

+0.23 (+2.56)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

+7.86 (+1.44%)

USD 108.00B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.67 (+1.30%)

USD 105.67B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.72 (+1.27%)

USD 104.83B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.16 (+1.04%)

USD 62.86B
VUSA:F Vanguard Funds Public Limited ..

+1.48 (+1.52%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+1.05 (+0.45%)

USD 49.04B
XJSE:F Xtrackers II - Japan Governmen..

+0.02 (+0.32%)

USD 41.48B
0ZC:F Zscaler Inc

+4.08 (+2.23%)

USD 37.92B
BSND:F Danone SA

+0.20 (+1.45%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

+1.74 (+1.38%)

USD 24.77B

ETFs Containing SLMC:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.89% 81% B- 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.89% 81% B- 73% C
Trailing 12 Months  
Capital Gain 12.15% 76% C+ 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.15% 72% C 57% F
Trailing 5 Years  
Capital Gain 117.12% 75% C 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 117.12% 75% C 50% F
Average Annual (5 Year Horizon)  
Capital Gain 12.71% 76% C+ 69% C-
Dividend Return 12.71% 74% C 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.00% 53% F 85% B
Risk Adjusted Return 97.78% 88% B+ 92% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike